Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousBone MarrowStem Cell TransplantationHematologic NeoplasmsBone Marrow CellsWhole-Body IrradiationTissue DonorsTransplantation ChimeraGraft SurvivalHistocompatibility TestingHematopoietic Stem CellsStem CellsKidney TransplantationHistocompatibilityLiver TransplantationTreatment OutcomeLeukemiaMyeloablative AgonistsPeripheral Blood Stem Cell TransplantationBusulfanImmunosuppressive AgentsAnemia, AplasticRecurrenceGraft RejectionTransplantationRetrospective StudiesUnrelated DonorsLeukemia, Myeloid, AcuteTime FactorsCord Blood Stem Cell TransplantationHeart TransplantationSurvival AnalysisRemission InductionCombined Modality TherapyBone and BonesCytomegalovirus InfectionsHLA AntigensHematopoiesisCyclophosphamideTransplantation ImmunologyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic DiseasesSurvival RateImmunosuppressionPrecursor Cell Lymphoblastic Leukemia-LymphomaLung TransplantationGraft vs Tumor EffectGraft vs Leukemia EffectHepatic Veno-Occlusive DiseaseCyclosporineChimerismMyelodysplastic SyndromesBone Marrow PurgingAcute DiseaseTransplantation, IsogeneicVidarabineCell TransplantationDisease-Free SurvivalMice, Inbred C57BLFollow-Up StudiesMultiple MyelomaLymphoma, Non-HodgkinSiblingsLymphocyte DepletionCell DifferentiationT-LymphocytesImmunocompromised HostHematopoietic Stem Cell MobilizationLeukemia, MyeloidLiving DonorsOrgan TransplantationMesenchymal Stem Cell TransplantationLymphocyte TransfusionAntigens, CD34Antineoplastic Combined Chemotherapy ProtocolsTransplantsOpportunistic InfectionsBone Marrow DiseasesAntilymphocyte SerumRisk FactorsRadiation ChimeraSevere Combined ImmunodeficiencyFlow CytometryMycosesMelphalanSalvage TherapyLeukocyte TransfusionPrognosisPostoperative ComplicationsDonor SelectionCytomegalovirusColony-Forming Units AssayHodgkin DiseaseEmbryonic Stem CellsCells, Cultured